Inventaire - your friends and communities are your best library - Inventaire

Comparison of hepatitis C virus treatment between incarcerated and community patients

author

Rob Striker

published in: Hepatology

date of publication: 2012-10-01

language: English

main subject: Hepatitis C virus, hepatitis C

Cites articles 29

Date

Title

Authors

2011-06-09

Outcomes of treatment for hepatitis C virus infection by primary care providers

Miriam Komaromy, Glen Murata, Paulina Deming
2011-03-31

Boceprevir for untreated chronic HCV genotype 1 infection

K. Rajender Reddy, Mark Sulkowski, Christopher L Bowlus, TRAN Albert
2011-07-12

Gaps in the achievement of effectiveness of HCV treatment in national VA practice
2011-05-29

Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
2010-07-01

High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C.
2010-07

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

Stefan Zeuzem, Fred Poordad, David M. Vock, Jacques Fellay, Rafael Esteban, Thierry Poynard, Karen S Pieper, Nezam Afdhal, Mark Sulkowski, Kevin V Shianna, David B. Goldstein, Dongliang Ge
2010-04-01

Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients.
2010-09-30

Induction pegylated interferon alfa-2a and high dose ribavirin do not increase SVR in heavy patients with HCV genotype 1 and high viral loads

K. Rajender Reddy
2009-09-17

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Jacques Fellay, Mark Sulkowski, Kevin V Shianna, Erin L Heinzen, David B. Goldstein, Dongliang Ge
2009-04-21

Chronic liver disease mortality among male prison inmates in Texas, 1989-2003.
2009-04-01

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

Mark Sulkowski, Lindsay McNair
2009-08-01

Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C
2008-12-01

Psychiatric disorders and repeat incarcerations: the revolving prison door

Ingrid A Binswanger
2008-11-01

Treating hepatitis C in the prison population is cost-saving

Sammy Saab
2008-10-01

Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations

Sanjay Basu, Frederick L Altice
2008-08-29

Access to treatment of hepatitis C in prison inmates

Joël Mossong
2006-05-01

A framework for management of hepatitis C in prisons

Harold S Margolis
2006-05-16

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
2004-04

Diagnosis, management, and treatment of hepatitis C

David L Thomas
2004-05-01

Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?
2003-01-24

Prevention and control of infections with hepatitis viruses in correctional settings

Harold S Margolis
2003-02-01

Treatment of chronic hepatitis C in a state correctional facility
2002-11

Natural history of chronic hepatitis C
2002-09-26

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Giampiero Carosi, Antonio Craxì, K. Rajender Reddy, Dieter Häussinger
2002-10-01

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C

Thierry Poynard, Jules Dienstag
2001-09-22

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael Manns
2000-02-01

Pathogenesis, natural history, treatment, and prevention of hepatitis C.
1990-08-01

Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism
1974-12

A new look at the statistical model identification

Hirotugu Akaike

Article - wd:Q35915031

Welcome to Inventaire

the library of your friends and communities

you are offline